1. Home
  2. EME vs TEVA Comparison

EME vs TEVA Comparison

Compare EME & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EMCOR Group Inc.

EME

EMCOR Group Inc.

HOLD

Current Price

$635.62

Market Cap

27.9B

Sector

Industrials

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$30.84

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EME
TEVA
Founded
1987
1901
Country
United States
Israel
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9B
30.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EME
TEVA
Price
$635.62
$30.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
9
Target Price
$693.60
$32.11
AVG Volume (30 Days)
363.0K
8.8M
Earning Date
10-30-2025
01-28-2026
Dividend Yield
0.16%
N/A
EPS Growth
26.22
N/A
EPS
24.83
0.62
Revenue
$16,243,320,000.00
$16,776,000,000.00
Revenue This Year
$16.15
$4.62
Revenue Next Year
$6.30
$0.34
P/E Ratio
$24.64
$50.57
Revenue Growth
14.11
0.02
52 Week Low
$320.89
$12.47
52 Week High
$778.64
$31.99

Technical Indicators

Market Signals
Indicator
EME
TEVA
Relative Strength Index (RSI) 54.91 68.81
Support Level $610.00 $31.17
Resistance Level $629.82 $31.99
Average True Range (ATR) 15.17 0.55
MACD 1.98 -0.20
Stochastic Oscillator 89.17 53.02

Price Performance

Historical Comparison
EME
TEVA

About EME EMCOR Group Inc.

EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: